The emergence of nanotechnology as a key enabling technology over the past years has
opened avenues for new and innovative applications in nanomedicine. From the business …

Background & Aims Evidence suggests that a fraction of new gastric cancer cases may be
etiologically associated with Epstein-Barr virus (EBV), a known carcinogenic agent. We …

Gastric cancer (GC) is a leading cause of worldwide cancer-related death. Being a highly
heterogeneous disease, the current treatment of GC has been suboptimal due to the lack of …

Gastric cancer (GC) pathogenesis is complex and heterogeneous, reflecting morphological,
molecular and genetic diversity. Diffuse gastric cancer (DGC) and intestinal gastric cancer …

Gastric cancer (GC) is a heterogeneous disease, often diagnosed at advanced stages, with
a 5-year survival rate of approximately 20%. Despite notable technological advancements in …

Gastric cancer (GC) is one of the leading causes of cancer-related death. The combination
of new molecular classifications with clinicopathological data could contribute to the …

Simple Summary In this study, we present a simple but comprehensive molecular analysis of
gastric carcinoma. The two major existing classification schemes show some discrepancies …

The Epstein–Barr virus (EBV) has been associated with gastric cancer (GC), one of the
deadliest malignancies in Chile and the world. Little is known about Chilean EBV strains …

Introduction Gastric cancer (GC) burden is currently evolving with regional differences
associated with complex behavioural, environmental, and genetic risk factors. The LEGACy …

Gastric cancer is the fifth most common cancer worldwide and the fourth most common
cause of cancer-related death. Two molecular subtyping classifications were recently …